Profile picture

Professor Horng Chen

Mayo Clinic, Rochester (United States of America)
Membership: ESC Professional Member HFA Member
Follow
Logo ESC

Contributor content

Safety, tolerability and blood pressure lowering of the innovative guanylyl cyclase a-receptor activator MANP in an ethnically diverse resistant hypertension population: a phase 1B clinical trial
Presentation
Safety, tolerability and blood pressure lowering of the innovative guanylyl cyclase a-receptor activator MANP in an ethnically diverse resistant hypertension population: a phase 1B clinical trial
Read more
Diabetes mellitus is a predictor of development of heart failure independent of HTN, CAD and diastolic function: a population based study
Presentation
Diabetes mellitus is a predictor of development of heart failure independent of HTN, CAD and diastolic function: a population based study
Read more
Novel Designer Natriuretic Peptide (ZD100) in Human Resistant-Like Hypertension - A First in Human Study
Presentation
Novel Designer Natriuretic Peptide (ZD100) in Human Resistant-Like Hypertension - A First in Human Study
Read more
Diastolic dysfunction has differential impact on clinical outcomes of diabetic versus non-diabetic patients hospitalized with acute heart failure: a population based study
Presentation
Diastolic dysfunction has differential impact on clinical outcomes of diabetic versus non-diabetic patients hospitalized with acute heart failure: a population based study
Read more

ESC 365 is supported by

novartis Explore sponsored resources